Updated guidelines for pulmonary arterial hypertension (PAH) were recently completed by a panel of experts from the Pulmonary Hypertension Association, American Thoracic Society and the American Heart Association and published in the CHEST Journal. The panel, which included several PHA members and a patient representative, looked at 300 recent studies to complete the update to the 2014 American College of Chest Physicians Guideline and Expert Panel Report on Pharmacotherapy for PAH.
Evidence-based studies on pharmacologic therapy, palliative care and supportive therapies were considered, leading to new recommendations on combination therapy and consensus-based statements on integrating palliative care and supervised exercise training (cardiopulmonary rehabilitation) to help manage PAH. “Importantly, we continue to suggest early referral to expert centers and collaborative care using sound clinical judgment,” the panel summarized.
To read the study, visit the CHEST journal.